REVIEW 3 major objections 3 minor 8 references
A Method for Characterizing Disease Progression from Acute Kidney Injury to Chronic Kidney Disease
T0 review · 3 major / 3 minor · reviewed 2026-05-17 · grok-4.3
Pith's one-line read Clustering post-AKI patient records identifies fifteen clinical states with distinct risks of developing chronic kidney disease.
desk verdict The paper clusters 20k AKI patients into 15 EHR-derived states and models CKD transitions, but offers no stability or validation checks on the clusters themselves. read the letter →
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
The reading
What carries the argument
Unsupervised clustering of longitudinal EHR vectors followed by multi-state transition modeling, which partitions AKI patients into groups whose probabilities of progressing to CKD can be estimated separately.
What would settle it
Apply the same clustering procedure to an independent cohort of AKI patients and check whether the identical fifteen states appear with comparable CKD transition rates.
Extended reading notes
Core claim
Using electronic health record data from 20,699 patients with acute kidney injury at admission, the authors clustered patient vectors built from longitudinal medical codes and creatinine measurements to define fifteen distinct post-AKI clinical states. Multi-state modeling estimated transition probabilities between states and to CKD, while survival analysis identified risk factors whose effects varied across states. In this cohort, 3,491 patients (17%) developed CKD, with 75% remaining in a single state or making only one transition.
Load-bearing premise
That the clusters formed from medical codes and creatinine values correspond to clinically meaningful and repeatable patient states rather than data artifacts.
Editorial extensions
If this is right
- Risk stratification tools could assign AKI patients to one of the fifteen states for tailored follow-up schedules.
- Survival models run within each state would highlight which factors, such as heart failure or liver disease, drive CKD in that specific group.
- Decision support systems could trigger alerts when a patient moves into a high-transition-probability state.
- Subpopulation-specific prevention strategies become feasible once states separate patients with different risk profiles.
Reading between the lines
- The same vector-and-clustering pipeline could be adapted to map progression in other acute-to-chronic transitions, such as acute liver injury to cirrhosis.
- Embedding the fifteen states into live EHR dashboards would allow real-time risk scoring without manual chart review.
- Prospective trials could test whether assigning patients to high-risk states and applying intensified care actually lowers observed CKD rates.
- Stability of the states over longer follow-up periods remains an open question that would affect long-term utility.
Signed reviews
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript describes a data-driven approach using EHR data from 20,699 AKI patients to identify 15 distinct post-AKI clinical states via unsupervised clustering of longitudinal medical codes and creatinine vectors. Multi-state modeling is then applied to estimate transitions to CKD (observed in 17% of the cohort), with 75% of patients showing zero or one transition. The work further examines state-specific effects of both established and novel risk factors via survival analysis, positioning the method as a foundation for risk stratification and decision-support tools.
Significance. If the states are shown to be stable and clinically meaningful, the combination of unsupervised clustering with multi-state modeling on longitudinal EHR data offers a scalable framework for dynamic characterization of AKI-to-CKD progression. The large cohort, quantification of transition patterns, and demonstration that risk-factor effects vary across states provide a concrete basis for personalized early-intervention strategies in nephrology. The approach is particularly valuable for its potential to move beyond static predictors toward trajectory-based risk assessment.
major comments (3)
- [Methods] Methods (clustering subsection): The choice of 15 clusters is presented without reported stability metrics (e.g., adjusted Rand index across bootstrap resamples or multiple initializations), silhouette scores, or external validation against clinical endpoints. Because the central claim of distinct states with differing CKD probabilities rests on these clusters being reproducible and non-artifactual, the absence of such checks is load-bearing.
- [Results] Results (transition probabilities and state occupancy): With only 3,491 patients (17%) progressing to CKD overall, the manuscript does not report the distribution of patients across the 15 states or confirm adequate per-state sample sizes for reliable multi-state model estimation. Small or imbalanced state populations would render transition probability estimates imprecise and undermine the risk-stratification utility.
- [Discussion] Discussion (risk-factor analysis): The claim that novel risk factors have state-varying impacts does not address potential confounding by unmeasured variables such as AKI etiology, care intensity, or socioeconomic factors. Without sensitivity analyses or explicit discussion of these, the observed heterogeneity could reflect data artifacts rather than true biological differences.
minor comments (3)
- [Abstract] Abstract: The stated 75% (n=15,607) with 0–1 transitions is slightly inconsistent with 0.75 × 20,699 ≈ 15,524; please verify the exact count and percentage.
- [Methods] Methods: The handling of missing longitudinal codes and creatinine values prior to vector construction and clustering is not described; explicit imputation or exclusion criteria would improve reproducibility.
- [Results] Figures/Tables: A state-transition diagram or example patient trajectories would aid interpretability of the 15 states and their progression patterns.
Simulated Author's Rebuttal
We thank the referee for their constructive and detailed comments. These have prompted us to strengthen the methodological transparency, reporting of sample distributions, and discussion of limitations in the revised manuscript. We address each major comment below.
read point-by-point responses
-
Referee: [Methods] Methods (clustering subsection): The choice of 15 clusters is presented without reported stability metrics (e.g., adjusted Rand index across bootstrap resamples or multiple initializations), silhouette scores, or external validation against clinical endpoints. Because the central claim of distinct states with differing CKD probabilities rests on these clusters being reproducible and non-artifactual, the absence of such checks is load-bearing.
Authors: We agree that explicit stability and validation metrics are necessary to substantiate the 15 states. In the revised Methods, we have added a dedicated paragraph on cluster determination: silhouette scores were computed for k = 5 to 25 (optimal at k=15), and stability was quantified via adjusted Rand index (mean 0.82, range 0.71-0.91) across 100 bootstrap resamples and 20 random k-means initializations. As external validation, we now report that the states exhibit significantly different CKD transition hazards (log-rank test p < 0.001 across states). These additions directly address the reproducibility concern. revision: yes
-
Referee: [Results] Results (transition probabilities and state occupancy): With only 3,491 patients (17%) progressing to CKD overall, the manuscript does not report the distribution of patients across the 15 states or confirm adequate per-state sample sizes for reliable multi-state model estimation. Small or imbalanced state populations would render transition probability estimates imprecise and undermine the risk-stratification utility.
Authors: We thank the referee for noting this omission. The revised Results section now includes Table 2, which tabulates patient counts per state (range: 712–2,845 patients; median 1,380). All 15 states exceed 700 patients, and we report the number of observed transitions and 95% confidence intervals for each state-specific transition probability to demonstrate estimation precision. These sample sizes support stable multi-state model fits, as confirmed by convergence diagnostics. revision: yes
-
Referee: [Discussion] Discussion (risk-factor analysis): The claim that novel risk factors have state-varying impacts does not address potential confounding by unmeasured variables such as AKI etiology, care intensity, or socioeconomic factors. Without sensitivity analyses or explicit discussion of these, the observed heterogeneity could reflect data artifacts rather than true biological differences.
Authors: We acknowledge that unmeasured confounding remains a concern. The revised Discussion now contains an expanded limitations paragraph that explicitly lists AKI etiology, care intensity, and socioeconomic status as potential unmeasured confounders not fully captured in the EHR. We note that the state-specific risk-factor patterns are biologically plausible and consistent with prior nephrology literature, yet we agree that formal sensitivity analyses would be ideal. Given data limitations, we have framed this as a key caveat and outlined how richer datasets could enable such checks in future work. revision: partial
Circularity Check
No significant circularity in derivation chain.
full rationale
The paper derives post-AKI states via unsupervised clustering on longitudinal medical codes and creatinine vectors, estimates transition probabilities with multi-state models, and identifies risk factors via survival analysis. These are standard empirical steps applied to observed EHR data; no load-bearing step reduces by the paper's equations or self-citation to a quantity defined solely by its own fitted parameters or inputs. The 15 states and varying CKD probabilities are outputs of the clustering and modeling procedures rather than self-definitional or renamed known results. The derivation remains self-contained against external data benchmarks with no evidence of circular reduction.
Assumptions & free parameters
free parameters (1)
- Number of clusters =
15
assumptions (2)
- domain assumption Longitudinal medical codes and creatinine measurements can be meaningfully vectorized to represent clinical states.
- domain assumption Multi-state models can estimate transition probabilities to CKD from longitudinal observations.
invented entities (1)
-
Fifteen distinct post-AKI clinical states
Cite this review
Pith. "Pith review of A Method for Characterizing Disease Progression from Acute Kidney Injury to Chronic Kidney Disease." pith.science (2026). https://pith.science/paper/2511.14603
@misc{pith2026251114603,
author = {Pith},
title = {Pith review of: A Method for Characterizing Disease Progression from Acute Kidney Injury to Chronic Kidney Disease},
year = {2026},
howpublished = {\url{https://pith.science/paper/2511.14603}},
note = {Machine review of arXiv:2511.14603}
}
read the original abstract
Patients with acute kidney injury (AKI) are at high risk of developing chronic kidney disease (CKD), but identifying those at greatest risk remains challenging. We used electronic health record (EHR) data to dynamically track AKI patients' clinical evolution and characterize AKI-to-CKD progression. Post-AKI clinical states were identified by clustering patient vectors derived from longitudinal medical codes and creatinine measurements. Transition probabilities between states and progression to CKD were estimated using multi-state modeling. After identifying common post-AKI trajectories, CKD risk factors in AKI subpopulations were identified through survival analysis. Of 20,699 patients with AKI at admission, 3,491 (17%) developed CKD. We identified fifteen distinct post-AKI states, each with different probabilities of CKD development. Most patients (75%, n=15,607) remained in a single state or made only one transition during the study period. Both established (e.g., AKI severity, diabetes, hypertension, heart failure, liver disease) and novel CKD risk factors, with their impact varying across these clinical states. This study demonstrates a data-driven approach for identifying high-risk AKI patients, supporting the development of decision-support tools for early CKD detection and intervention.
Figures
Lean theorems connected to this paper
-
IndisputableMonolith/Foundation/AbsoluteFloorClosure.leanreality_from_one_distinction unclear?
unclearRelation between the paper passage and the cited Recognition theorem.
Post-AKI clinical states were identified by clustering patient vectors derived from longitudinal medical codes and creatinine measurements... elbow method with the Within-Cluster Sum of Squares (WCSS)... K=15
-
IndisputableMonolith/Cost/FunctionalEquation.leanwashburn_uniqueness_aczel unclear?
unclearRelation between the paper passage and the cited Recognition theorem.
Transition probabilities between states and progression to CKD were estimated using multi-state modeling... Aalen-Johansen estimator
What do these tags mean?
- matches
- The paper's claim is directly supported by a theorem in the formal canon.
- supports
- The theorem supports part of the paper's argument, but the paper may add assumptions or extra steps.
- extends
- The paper goes beyond the formal theorem; the theorem is a base layer rather than the whole result.
- uses
- The paper appears to rely on the theorem as machinery.
- contradicts
- The paper's claim conflicts with a theorem or certificate in the canon.
- unclear
- Pith found a possible connection, but the passage is too broad, indirect, or ambiguous to say the theorem truly supports the claim.
Reference graph
Works this paper leans on
-
[1]
INTRODUCTION Clinicians continually seek new knowledge and a deeper understanding of how diseases present and why they progress. Researchers are called to develop methods that effectively extract clinically meaningful information from large datasets to support decision-making and personalized care.1,2 Analyzing longitudinal real-world electronic health re...
-
[2]
Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. Jun 2009;53(6):961–73. doi:10.1053/j.ajkd.2008.11.034 12. James MT, Bhatt M, Pannu N, Tonelli M. Long-term outcomes of acute kidney injury and strategies for improved ca...
-
[3]
Precision management of acute kidney injury in the intensive care unit: current state of the art
Stanski NL, Rodrigues CE, Strader M, Murray PT, Endre ZH, Bagshaw SM. Precision management of acute kidney injury in the intensive care unit: current state of the art. Intensive Care Med. Sep 2023;49(9):1049–1061. doi:10.1007/s00134-023-07171-z 22. Wiersema R, Jukarainen S, Vaara ST, et al. Two subphenotypes of septic acute kidney injury are associated wi...
-
[4]
Lenzi J, Messina R, Rosa S, et al. A multi-state analysis of disease trajectories and mental health transitions in patients with type 2 diabetes: A population-based retrospective cohort study utilizing health administrative data. Diabetes Res Clin Pract. Mar 2024;209:111561. doi:10.1016/j.diabres.2024.111561 31. Jeong WG, Choi H, Chae KJ, Kim J. Prognosis...
-
[5]
Onk OA, Onk D, Ozcelik F , Gunay M, Turkmen K. Risk Factors for Acute Kidney Injury after Coronary Artery Bypass Surgery and Its Detection Using Neutrophil Gelatinase-Associated Lipocalin. Cardiorenal Med. May 2016;6(3):216–29. doi:10.1159/000444099 49. Xu T, Lin MN, Shen XH, et al. Association of the classification and severity of heart failure with the i...
-
[6]
Journal of the Royal Statistical Society: Series B (Methodological)57(1), 289–300 (1995)
Benjamini Y , Hochberg Y . Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological). 1995;57(1):289–300. doi:https://doi.org/10.1111/j.2517-6161.1995.tb02031.x 61. McInnes L, Healy J, Melville J. Umap: Uniform manifold approximation and projection for d...
-
[7]
EHR-Based Clinical Trials: The Next Generation of Evidence
Abdel-Kader K, Jhamb M. EHR-Based Clinical Trials: The Next Generation of Evidence. Clin J Am Soc Nephrol. Jul 1 2020;15(7):1050–1052. doi:10.2215/CJN.11860919 71. Chou YH, Huang TM, Pan SY , et al. Renin-Angiotensin System Inhibitor is Associated with Lower Risk of Ensuing Chronic Kidney Disease after Functional Recovery from Acute Kidney Injury. Sci Rep...
-
[8]
Other” category of self-reported races includes “Native Hawaiian or Other Pacific Islander,
Nadkarni GN, Gottesman O, Linneman JG, et al. Development and validation of an electronic phenotyping algorithm for chronic kidney disease. AMIA Annu Symp Proc. 2014;2014:907–16. 81. Khan A, Turchin MC, Patki A, et al. Genome-wide polygenic score to predict chronic kidney disease across ancestries. Nat Med. Jul 2022;28(7):1412–1420. doi:10.1038/s41591-022...
Reviewed May 17, 2026 · model on record in the stance chip above.
Discussion (0). Continue with ORCID to comment.